LIPOCINE INC. Payments to Acquire Available-for-sale Securities
LIPOCINE INC. (LPCN) reported Payments to Acquire Available-for-sale Securities of $12.53 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecurities · last filed 2019-08-07
- LIPOCINE INC. payments to acquire available-for-sale securities for the quarter ending 2019-06-30 was $5.75M, a 63.33% increase year-over-year.
- LIPOCINE INC. payments to acquire available-for-sale securities for the quarter ending 2019-03-31 was $6.78M, a 48.66% decline year-over-year.
- LIPOCINE INC. payments to acquire available-for-sale securities for the quarter ending 2018-12-31 was $4.85M, a 41.58% decline year-over-year.
- LIPOCINE INC. payments to acquire available-for-sale securities for the quarter ending 2018-09-30 was $3.97M, a 70.81% decline year-over-year.
- LIPOCINE INC. payments to acquire available-for-sale securities for fiscal 2018 was $25.55M, a 22.70% decline from fiscal 2017.
- LIPOCINE INC. payments to acquire available-for-sale securities for fiscal 2017 was $33.06M, a 30.80% increase from fiscal 2016.
- LIPOCINE INC. payments to acquire available-for-sale securities for fiscal 2016 was $25.27M, a 2.01% decline from fiscal 2015.
- LIPOCINE INC. payments to acquire available-for-sale securities for fiscal 2015 was $25.79M.
| Period end | Payments to Acquire Available-for-sale Securities 3 month | Payments to Acquire Available-for-sale Securities 6 month | Payments to Acquire Available-for-sale Securities 9 month | Payments to Acquire Available-for-sale Securities 12 month |
|---|---|---|---|---|
| 2019-06-30 | $5.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $12.53M 10-Q · filed 2019-08-07 | $17.38M derived: sum of 3 quarters · filed 2019-08-07 | $21.35M derived: sum of 4 quarters · filed 2019-08-07 |
| 2019-03-31 | $6.78M 10-Q · filed 2019-05-08 | $11.64M derived: sum of 2 quarters · filed 2019-05-08 | $15.61M derived: sum of 3 quarters · filed 2019-05-08 | $19.12M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-12-31 | $4.85M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $8.82M derived: sum of 2 quarters · filed 2019-03-06 | $12.34M derived: sum of 3 quarters · filed 2019-08-07 | $25.55M 10-K · filed 2019-03-06 |
| 2018-09-30 | $3.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $7.49M derived: sum of 2 quarters · filed 2019-08-07 | $20.70M 10-Q · filed 2018-11-07 | $29.01M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-06-30 | $3.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $16.73M 10-Q · filed 2019-08-07 | $25.04M derived: sum of 3 quarters · filed 2019-08-07 | $38.63M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $13.21M 10-Q · filed 2019-05-08 | $21.52M derived: sum of 2 quarters · filed 2019-05-08 | $35.12M derived: sum of 3 quarters · filed 2019-05-08 | $39.29M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $8.31M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $21.91M derived: sum of 2 quarters · filed 2019-03-06 | $26.08M derived: sum of 3 quarters · filed 2019-03-06 | $33.06M 10-K · filed 2019-03-06 |
| 2017-09-30 | $13.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $17.77M derived: sum of 2 quarters · filed 2018-11-07 | $24.75M 10-Q · filed 2018-11-07 | $30.81M derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-06-30 | $4.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $11.15M 10-Q · filed 2018-08-07 | $17.21M derived: sum of 3 quarters · filed 2019-03-06 | $32.45M derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-03-31 | $6.97M 10-Q · filed 2018-05-07 | $13.03M derived: sum of 2 quarters · filed 2019-03-06 | $28.27M derived: sum of 3 quarters · filed 2019-03-06 | $29.07M derived: sum of 4 quarters · filed 2019-03-06 |
| 2016-12-31 | $6.06M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $21.30M derived: sum of 2 quarters · filed 2019-03-06 | $22.09M derived: sum of 3 quarters · filed 2019-03-06 | $25.27M 10-K · filed 2019-03-06 |
| 2016-09-30 | $15.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $16.04M derived: sum of 2 quarters · filed 2017-11-08 | $19.21M 10-Q · filed 2017-11-08 | $21.02M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $798.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $3.98M 10-Q · filed 2017-08-07 | $5.78M derived: sum of 3 quarters · filed 2018-03-12 | $14.64M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $3.18M 10-Q · filed 2017-05-08 | $4.98M derived: sum of 2 quarters · filed 2018-03-12 | $13.84M derived: sum of 3 quarters · filed 2018-03-12 | $28.97M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $10.66M derived: sum of 2 quarters · filed 2018-03-12 | $25.79M derived: sum of 3 quarters · filed 2018-03-12 | $25.79M 10-K · filed 2018-03-12 |
| 2015-09-30 | $8.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $23.98M derived: sum of 2 quarters · filed 2016-11-08 | $23.98M 10-Q · filed 2016-11-08 | $23.98M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $15.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $15.13M 10-Q · filed 2016-08-09 | $15.13M derived: sum of 3 quarters · filed 2017-03-06 | $15.13M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-09 | $0.00 derived: sum of 2 quarters · filed 2017-03-06 | $0.00 derived: sum of 3 quarters · filed 2017-03-06 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $0.00 derived: sum of 2 quarters · filed 2017-03-06 | $0.00 10-K · filed 2017-03-06 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |